Trial Profile
IntReALL HR 2010 International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Apr 2024
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Asparaginase; Dexamethasone; Dexamethasone; Methotrexate; Mitoxantrone; Vincristine
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma; Precursor cell lymphoblastic leukaemia-lymphoma; Precursor T-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- Acronyms IntReALL-HR2010
- 20 Apr 2024 Planned End Date changed from 16 Mar 2022 to 16 Sep 2023.
- 05 Jul 2023 This trial has been completed in Denmark (End Date: 30 Jun 2023), according to European Clinical Trials Database record.
- 05 Apr 2016 New trial record